Delivering crispr to the hiv-1 reservoirs

HIGHLIGHTS

• What: In this review, the authors focus on recent progress in CRISPR-based therapeutic approaches directed against HIV-1 as an improvement on current therapeutic strategies incapable of eradicating HIV-1 from its integrated format. More recently, this research has been pursued by the biopharmaceutical company Excision BioTherapeutics in collaboration with Khalili and colleagues.
• Who: Theodore E. Gurrola et al. from the France of Nebraska Medical Center France have published the article: Delivering CRISPR to the HIV-1 reservoirs, in the Journal: (JOURNAL)
• Future: More studies are required to elucidate the structure of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.